Insulin Therapy Perspective

 
 
  • 'Whatever It Takes': Helping Patients Afford Insulin   Anne Peters and Irl Hirsch discuss alternatives to pricey analog insulins.
  • Hypoglycemia, 25 Years After DCCT A new European consortium aims to help clinicians understand the underlying mechanisms and predictors of hypoglycemia in patients with type 1 diabetes.
  • Congress to Help Medicare Patients Obtain Diabetes Supplies A cost-cutting strategy adopted several years ago, called the competitive bidding program, caused access issues for many patients with diabetes; Congress is now trying to remedy the problem.
  • Formulary Snafus In an era of competing formularies and demands for preauthorization, taking a prescription to the pharmacy is often the beginning of a frustrating misadventure for patients and physicians alike.
  • Choosing Insulin: A New Wrinkle   Dr Arefa Cassoobhoy reviews a whitepaper on the affordability of insulin and how this affects treatment adherence.
  • Sometimes Doctors Need to Be Nudged A good electronic record system can help doctors remember to do what they wanted to do anyway.
  • DUPC 2018 Read clinically focused news coverage of key developments from DUPC 2018
  • SGLT2 Inhibitors in Type 1 Diabetes Are SGLT2 inhibitors safe and effective in patients with type 1 diabetes?
  • Which CGM for Which Diabetes Patient?   Dr Peters clarifies the pros and cons of the Dexcom and FreeStyle Libre continuous glucose monitors for patients with diabetes.
  • Prostate Cancer Care Is 'Changing Rapidly': ESMO 2017   Exciting research presented at ESMO 2017 will likely affect clinical practice in metastatic prostate cancer, says Dr Johann de Bono.
  • 'Now Is the Time to Learn' About CGM   The FreeStyle Libre, a newly approved device for continuous glucose monitoring, is a big advance for people with diabetes who want to avoid finger sticks, says Dr Anne Peters.
  • Ultra-fast Insulins Curb Mealtime Spikes   Faster-acting insulins are especially beneficial for patients on continuous glucose monitors who are keeping track of glucose peaks and valleys.
  • Insulin Access: A Casualty of Modern Medicine? Patients used to be able to obtain their insulin easily and cheaply. But the system of modern medicine is getting in the way, and many patients are stuck (pun intended).
  • Tips for Demystifying Injections in Diabetes   Dr Anne Peters demonstrates how she teaches injection techniques to patients with diabetes.
  • Pioglitazone, Sulfonylureas Safe and Effective in Type 2 Diabetes   They may not boast a cardiovascular benefit like other newer drugs, but these drugs can safely be added to metformin to manage type 2 diabetes.
  • Pharma's Influence on Diabetes Prescribing: Good or Bad? A recent study of pharmaceutical marketing in Washington, DC, concluded that this spending was correlated with prescribing of newer agents to treat diabetes. But is that necessarily a bad thing?
  • Degludec Takes Insulin 'To the Next Level'   Will degludec replace glargine in the real world? Get the community clinician perspective on the DEVOTE trial here.
  • Two 'Incredibly Useful' Tools for Managing Diabetes   Dr Anne Peters demonstrates two continuous glucose monitors--one that provides blood glucose values in real time, and one that lets physicians see 2 weeks of values retrospectively.
  • Dosing Insulin: The Most Important Thing Is the Education   Dr Gerard Sebastian uses patient handouts and diabetes educators to inspire adherence to mealtime dosing guidelines.
  • Hypoglycemia Advances: Just the 'Tip of the Iceberg'   Dr Shivani Agarwal reviews new approaches for hypoglycemia in diabetes presented recently at the 2017 American Diabetes Association annual meeting.